Twilight Bioscience, Inc.

Topsfield, MA Part of Formation Venture Engineering Foundry Inc.

UEI
YTMPKL72Y4H7
CAGE
9TWN2
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
Corporate family
SAM.gov registration date
Physical address
47 Fox Run Rd, Topsfield, MA 01983, USA
Website
twlbio.com
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Twilight Bioscience, Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Integrated precision immunology approach for developing an FC-fusion vaccine to treat frontotemporal dementia Grant · HT94252510070 Defense Health Agency $300,387

Quick answers

What is Twilight Bioscience, Inc.'s UEI?

Twilight Bioscience, Inc.'s Unique Entity ID (UEI) in SAM.gov is YTMPKL72Y4H7.

What is Twilight Bioscience, Inc.'s CAGE code?

Twilight Bioscience, Inc.'s CAGE code is 9TWN2.

What is Twilight Bioscience, Inc.'s primary NAICS code?

Twilight Bioscience, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Twilight Bioscience, Inc. located?

Twilight Bioscience, Inc.'s physical address in SAM.gov is 47 Fox Run Rd, Topsfield, MA 01983, USA.

Is Twilight Bioscience, Inc. registered in SAM.gov?

Yes. Twilight Bioscience, Inc.'s SAM.gov registration is active through April 1, 2027.

Who is Twilight Bioscience, Inc.'s parent company?

Twilight Bioscience, Inc. is part of Formation Venture Engineering Foundry Inc.

What is Twilight Bioscience, Inc.'s most recent federal award?

Twilight Bioscience, Inc.'s most recent federal grant award is Integrated precision immunology approach for developing an FC-fusion vaccine to treat frontotemporal dementia (HT94252510070), from Defense Health Agency, on February 1, 2025.

On GovTribe

See Twilight Bioscience, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login